⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14343220 | 0.92 | — | — | |
| SCHEMBL175373 | 0.90 | — | — | |
| SCHEMBL735857 | 0.84 | — | — | |
| SCHEMBL735469 | 0.84 | CTDSP1 (0.31) | — | |
| SCHEMBL6641164 | 0.82 | CTDSP1 (0.34) | — | |
| SCHEMBL738719 | 0.82 | CTDSP1 (0.34) | — | |
| SCHEMBL736119 | 0.82 | SLC18A3 (0.31) | — | |
| SCHEMBL735596 | 0.82 | CTDSP1 (0.34) | — | |
| SCHEMBL204448 | 0.82 | HTR6 (0.31) | — | |
| SCHEMBL2009169 | 0.82 | SLC18A3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1726 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12012404-B2 | Pyrimidoheterocyclic compounds and application thereof | D3 BIO (WUXI) CO., LTD. (CN) | 2024-06-18 | — | — | US | claimed |
| US-20240174692-A1 | PYRIMIDINE AROMATIC RING COMPOUNDS | MEDSHINE DISCOVERY INC. (CN) | 2024-05-30 | — | — | US | claimed |
| EP-4373827-A1 | KRAS G12D INHIBITORS AND USES THEREOF | Suzhou Zanrong Pharma Limited (CN) | 2024-05-29 | — | — | EP | claimed |
| US-20240140957-A1 | BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF | BEONE MEDICINES I GMBH (CH) | 2024-05-02 | — | — | US | claimed |
| WO-2024083223-A1 | MACROCYCLIC COMPOUNDS AND MEDICAL USE THEREOF | 正大天晴药业集团股份有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-117917416-A | KRAS G12D degradation agent and preparation method and application thereof | 上海领泰生物医药科技有限公司 | 2024-04-23 | — | — | CN | claimed |
| CN-114615981-B | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20240116934-A1 | PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF | D3 BIO (WUXI) CO., LTD. (CN) | 2024-04-11 | — | — | US | claimed |
| EP-4349828-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Yingli Pharmaceutical Co. Ltd. (CN) | 2024-04-10 | — | — | EP | claimed |
| US-20240101553-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | claimed |
| EP-1537226-A1 | METHOD FOR REPRODUCING PLEUROMUTILINS | GLAXO GROUP LIMITED (GB) | 2005-06-08 | — | — | EP | claimed |
| EP-1028961-B1 | PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALS | SMITHKLINE BEECHAM PLC (GB) | 2004-09-29 | — | — | EP | claimed |
| EP-1452534-A1 | PLEUROMUTLIN DERIVATIVES AS ANTIMICROBIALS | SMITHKLINE BEECHAM PLC (GB) | 2004-09-01 | — | — | EP | claimed |
| WO-2004015122-A1 | METHOD FOR REPRODUCING PLEUROMUTILINS | GLAXO GROUP LIMITED (GB) | 2004-02-19 | — | — | WO | claimed |
| US-20030027845-A1 | Ether derivatives useful as inhibitors of PDE4 isozymes | PFIZER INC. | 2003-02-06 | — | — | US | claimed |
| US-6281226-B1 | Pleuromutilin derivatives as antimicrobials | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-08-28 | — | — | US | claimed |
| US-6156752-A | Optically active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC (US) | 2000-12-05 | — | — | US | claimed |
| EP-1028961-A1 | PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALS | SMITHKLINE BEECHAM PLC (GB) | 2000-08-23 | — | — | EP | claimed |
| WO-1999021855-A1 | PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALS | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-05-06 | — | — | WO | claimed |
| EP-0899261-A1 | Optical active 1,4-dihydropyridine compounds as bradykinin antagonists | PFIZER INC. (US) | 1999-03-03 | — | — | EP | claimed |